SPRO
Spero Therapeutics Inc
1.20$
-1.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -209.9% | – | -415.7% | – | -283.4% | – | – | – | -147.9% | – | -133.8% | – | |
| – | -64.8% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | +4.7% | +1.3% | +4.4% | +1.9% | -30.2% | +3.5% | -54.1% | +46.8% | -3.9% | +10.6% | -26.2% | – | |
| – | -714.2% | – | -119.9% | – | -115.6% | – | -311.4% | – | -279.6% | – | -85.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -208.4% | – | -415.7% | – | -283.4% | – | – | – | -147.9% | – | -133.8% | – | |
| – | -209.9% | – | -415.7% | – | -283.4% | – | – | – | -147.9% | – | -133.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.